Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 0904-6290

6 FDA label images from Major Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 0904-6290). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 01

Figure 01
A line chart showing cumulative incidence (%) over time (years) comparing Atorvastatin versus placebo. The graph features two lines, one solid representing Atorvastatin and one dashed representing placebo, with Atorvastatin showing lower cumulative incidence. The chart includes a hazard ratio (HR=0.64) with confidence interval and p-value indicating statistical significance.*
FDA Label Image

Figure 02

Figure 02
A line graph depicting cumulative hazard percentage over time in years, comparing placebo and atorvastatin groups through four years of follow-up. The placebo group is represented by a dashed line showing a higher cumulative hazard compared to the solid line for atorvastatin. The graph includes a hazard ratio (HR) of 0.63 with a confidence interval and a p-value of 0.001.*
FDA Label Image

Figure 03

Figure 03
A line graph showing the percentage of subjects experiencing a major cardiovascular event over time in years, comparing atorvastatin 10 mg and atorvastatin 80 mg. The horizontal axis represents time to first major cardiovascular endpoint up to 5 years, and the vertical axis shows the percentage of subjects experiencing the event. A hazard ratio (HR) of 0.78 with confidence interval and p-value is noted.*
FDA Label Image

Chemical Structure

Chemical Structure
Chemical structure of atorvastatin calcium, shown as two calcium ions (Ca2+) complexed with the atorvastatin molecule and its associated chemical groups.*
FDA Label Image

Fc666797 D7b0 C116 714a Bbaa9c0db62d 00

Fc666797 D7b0 C116 714a Bbaa9c0db62d 00
Packaging label for ATORVASTATIN CALCIUM tablets, USP, 20 mg film-coated tablets by Major Pharmaceuticals. The label indicates the product is unit dose with 100 tablets per container and includes storage instructions, dosing notes, and distribution information. The label prominently displays the strength and important dispensing instructions for pharmacists.*
FDA Label Image

Fc666797 D7b0 C116 714a Bbaa9c0db62d 01

Fc666797 D7b0 C116 714a Bbaa9c0db62d 01
Packaging label for ATORVASTATIN CALCIUM 10 mg film-coated tablets by Major Pharmaceuticals. The label shows the product as unit dose, with 100 tablets per package. It includes dosing and storage instructions, pharmacist dispensing information, Rx only designation, and a barcode. Distributed by Major Pharmaceuticals, Livonia, MI.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.